{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:43:24Z","timestamp":1789523004312,"version":"build-2803163510"},"reference-count":64,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Scottish Clinical Academic Fellowship"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Pharmacist independent prescribers (PIPs) enhance patient care but there is variability in their integration in community pharmacy (CP). The objective was to collate and characterize literature on the integration of \u2018standard of care\u2019 model PIPs in CP for acute common clinical conditions (CCCs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This review followed the Arksey and O\u2019Malley framework. Eligibility criteria, search databases, and terms were defined. Information sources were searched from January 2006 to October 2023. Following screening, full text review, and data extraction a narrative synthesis approach was used to address the review objectives. All steps were independently checked by two of the review team. Barriers and facilitators for integration used the Consolidated Framework for Implementation Research as a theoretical lens.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key findings<\/jats:title>\n                    <jats:p>Ten papers remained for full text review from 1075 records. Most studies were from Canada and focused on pharmacist views, evaluation of safety, effectiveness, and patient satisfaction. A range of CCCs were included with a focus on antimicrobial prescribing. A wide range of barriers and facilitators influencing implementation were identified including; \u2018regulatory constraints\u2019 and \u2018fiscal challenges\u2019 at a macro socio-organizational level and several challenges within organizations; lack of clarity on the pharmacists\u2019 scopes of practice and linked consumer confusion, staffing levels, and workload with specific mention of paperwork and access to patient records.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Most evidence for CCC management by PIPs relates to antimicrobials, originates in Canada and identifies multiple challenges. Given this there is a need to consider this topic further to identify ways to address the challenges and facilitate integration of PIPs in CP.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ijpp\/riaf063","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T10:13:19Z","timestamp":1752747199000},"page":"597-612","source":"Crossref","is-referenced-by-count":9,"title":["A scoping review of evidence of community pharmacist independent prescribing for common clinical conditions: beyond protocol prescribing"],"prefix":"10.1093","volume":"33","author":[{"given":"Laura","family":"Karim","sequence":"first","affiliation":[{"name":"School of Pharmacy, Applied Sciences and Public Health, Robert Gordon University , Garthdee Road, Aberdeen, AB10 7GJ ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trudi","family":"McIntosh","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Applied Sciences and Public Health, Robert Gordon University , Garthdee Road, Aberdeen, AB10 7GJ ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tesnime","family":"Jebara","sequence":"additional","affiliation":[{"name":"Health Services and Population Science Department, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London , De Crespigny Park, London, SE5 8AF ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9655-2245","authenticated-orcid":false,"given":"Scott","family":"Cunningham","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Applied Sciences and Public Health, Robert Gordon University , Garthdee Road, Aberdeen, AB10 7GJ ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"key":"2025120323314332600_ref1","doi-asserted-by":"publisher","first-page":"e0214630","DOI":"10.1371\/journal.pone.0214630","article-title":"Non-medical prescribing in the United Kingdom National Health Service: a systematic policy review","volume":"14","author":"Graham-Clarke","year":"2019","journal-title":"PLoS One"},{"key":"2025120323314332600_ref2","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/jac5.1245","article-title":"Current status of prescriptive authority by pharmacists in the United States","volume":"3","author":"Sachdev","year":"2020","journal-title":"J Am Coll Clin Pharm"},{"key":"2025120323314332600_ref3","author":"Canadian Pharmacists Association"},{"key":"2025120323314332600_ref4","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1186\/s12913-021-06435-y","article-title":"Examining non-medical prescribing trends in New Zealand: 2016\u20132020","volume":"21","author":"Raghunandan","year":"2021","journal-title":"BMC Health Serv Res"},{"key":"2025120323314332600_ref5","volume-title":"Improving Patients\u2019 Access to Medicines: A Guide to Implementing Nurse and Pharmacist Independent Prescribing within the NHS in England","author":"Department of Health UK","year":"2006"},{"key":"2025120323314332600_ref6","doi-asserted-by":"publisher","first-page":"CD011227","DOI":"10.1002\/14651858.CD011227.pub2","article-title":"Non-medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care","volume":"2017","author":"Weeks","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2025120323314332600_ref7","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1111\/bcp.13624","article-title":"Stakeholders\u2019 views and experiences of pharmacist prescribing: a systematic review","volume":"84","author":"Jebara","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"2025120323314332600_ref8","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1177\/1715163515608399","article-title":"A scoping review of research on the prescribing practice of Canadian pharmacists","volume":"148","author":"Faruquee","year":"2015","journal-title":"Can Pharm J (Ott)"},{"key":"2025120323314332600_ref9","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/pharmacy9020092","article-title":"Perceptions of independent pharmacist prescribing among health authority- and community-based pharmacists in northern British Columbia","volume":"9","author":"Lewis","year":"2021","journal-title":"Pharmacy (Basel)"},{"key":"2025120323314332600_ref10","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.2146\/ajhp150691","article-title":"Qualitative interviews regarding pharmacist prescribing in the community setting","volume":"73","author":"Feehan","year":"2016","journal-title":"Am J Health Syst Pharm"},{"key":"2025120323314332600_ref11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11096-006-9018-6","article-title":"Independent prescribing by pharmacists: a study of the awareness, views and attitudes of Scottish community pharmacists","volume":"28","author":"George","year":"2006","journal-title":"Pharm World Sci"},{"key":"2025120323314332600_ref12","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1002\/jac5.1465","article-title":"Pharmacist scope of practice expansion: the virtue of forbearance","volume":"4","author":"Adams","year":"2021","journal-title":"J Am Coll Clin Pharm"},{"key":"2025120323314332600_ref13","doi-asserted-by":"publisher","first-page":"e052227","DOI":"10.1136\/bmjopen-2021-052227","article-title":"Barriers and facilitators to implementation of non-medical independent prescribing in primary care in the UK: a qualitative systematic review","volume":"12","author":"Edwards","year":"2022","journal-title":"BMJ Open"},{"key":"2025120323314332600_ref14","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.sapharm.2017.10.004","article-title":"Identification of the relationship between barriers and facilitators of pharmacist prescribing and self-reported prescribing activity using the theoretical domains framework","volume":"14","author":"Isenor","year":"2018","journal-title":"Res Social Adm Pharm"},{"key":"2025120323314332600_ref15","doi-asserted-by":"publisher","first-page":"e006261","DOI":"10.1136\/bmjopen-2014-006261","article-title":"A cohort study of influences, health outcomes and costs of patients\u2019 health-seeking behaviour for minor ailments from primary and emergency care settings","volume":"5","author":"Watson","year":"2015","journal-title":"BMJ Open"},{"key":"2025120323314332600_ref16","doi-asserted-by":"publisher","first-page":"e472","DOI":"10.3399\/bjgp13X669194","article-title":"Are pharmacy-based minor ailment schemes a substitute for other service providers? A systematic review","volume":"63","author":"Paudyal","year":"2013","journal-title":"Br J Gen Pract"},{"key":"2025120323314332600_ref17","doi-asserted-by":"publisher","first-page":"e14424","DOI":"10.1111\/ijcp.14424","article-title":"Community pharmacists\u2019 management of minor ailments in developing countries: a systematic review of types, recommendations, information gathering and counselling practices","volume":"75","author":"Yusuff","year":"2021","journal-title":"Int J Clin Pract"},{"key":"2025120323314332600_ref18","author":"Canadian Pharmacists Association"},{"key":"2025120323314332600_ref19","author":"Federation International Pharmaceutical (FIP)","year":"2023"},{"key":"2025120323314332600_ref20","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.sapharm.2024.12.008","article-title":"Pharmacists as independent prescribers in community pharmacy: a scoping review","volume":"21","author":"Mesbahi","year":"2025","journal-title":"Res Social Adm Pharm"},{"key":"2025120323314332600_ref21","author":"Royal Pharmaceutical Society of Great Britain"},{"key":"2025120323314332600_ref22","author":"Canadian Pharmacists Association","year":"2023"},{"key":"2025120323314332600_ref23","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.2146\/ajhp150786","article-title":"The road to pharmacist prescribing in Alberta Health Services","volume":"73","author":"Gray","year":"2016","journal-title":"Am J Health Syst Pharm"},{"key":"2025120323314332600_ref24","doi-asserted-by":"publisher","first-page":"100357","DOI":"10.1016\/j.rcsop.2023.100357","article-title":"Managing common ambulatory conditions: exploring clinical decision making performance between pharmacists and family physicians","volume":"12","author":"Chiang","year":"2023","journal-title":"Explor Res Clin Soc Pharm"},{"key":"2025120323314332600_ref25","author":"UK Government","year":"2006"},{"key":"2025120323314332600_ref26","author":"Royal Pharmaceutical Society of Great Britain","year":"2022"},{"key":"2025120323314332600_ref27","author":"Scottish Government, NHS Scotland","year":"2020"},{"key":"2025120323314332600_ref28","author":"Scottish Government, NHS Scotland"},{"key":"2025120323314332600_ref29","author":"Welsh Government, NHS Wales"},{"key":"2025120323314332600_ref30","author":"UK Government, NHS England"},{"key":"2025120323314332600_ref31","author":"Health and Social Care, Northern Ireland"},{"key":"2025120323314332600_ref32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework","volume":"8","author":"Arksey","year":"2005","journal-title":"Int J Soc Res Methodol"},{"key":"2025120323314332600_ref33","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"2025120323314332600_ref34","author":"Ryan","year":"2013"},{"key":"2025120323314332600_ref35","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13012-022-01245-0","article-title":"The updated consolidated framework for implementation research based on user feedback","volume":"17","author":"Damschroder","year":"2022","journal-title":"Implement Sci"},{"key":"2025120323314332600_ref36","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13012-015-0242-0","article-title":"Making sense of implementation theories, models and frameworks","volume":"10","author":"Nilsen","year":"2015","journal-title":"Implement Sci"},{"key":"2025120323314332600_ref37","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2025120323314332600_ref38","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1177\/1715163518781175","article-title":"Outcomes of urinary tract infection management by pharmacists (RxOUTMAP): a study of pharmacist prescribing and care in patients with uncomplicated urinary tract infections in the community","volume":"151","author":"Beahm","year":"2018","journal-title":"Can Pharm J (Ott)"},{"key":"2025120323314332600_ref39","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3138\/jammi-2020-0047","article-title":"Antimicrobial utilization and stewardship in patients with uncomplicated urinary tract infections managed by pharmacists in the community: a sub-study of the RxOUTMAP trial","volume":"6","author":"Beahm","year":"2021","journal-title":"J Assoc Med Microbiol Infect Dis Can"},{"key":"2025120323314332600_ref40","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.sapharm.2022.08.014","article-title":"Increased self-reported pharmacist prescribing during the COVID-19 pandemic: using the theoretical domains framework to identify barriers and facilitators to prescribing","volume":"19","author":"Grant","year":"2023","journal-title":"Res Social Adm Pharm"},{"key":"2025120323314332600_ref41","doi-asserted-by":"publisher","first-page":"100221","DOI":"10.1016\/j.rcsop.2023.100221","article-title":"Uptake of community pharmacist prescribing over a three-year period","volume":"9","author":"Grant","year":"2023","journal-title":"Explor Res Clin Soc Pharm"},{"key":"2025120323314332600_ref42","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1093\/ijpp\/riab006","article-title":"Economic evaluation of pharmacists prescribing for minor ailments in Ontario, Canada: a cost-minimization analysis","volume":"29","author":"Kim","year":"2021","journal-title":"Int J Pharm Pract"},{"key":"2025120323314332600_ref43","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2147\/IPRP.S395322","article-title":"Community pharmacists\u2019 views on the early stages of implementation of a National Pilot Independent Prescribing Service in Wales: a qualitative study","volume":"12","author":"Mantzourani","year":"2023","journal-title":"Integr Pharm Res Pract"},{"key":"2025120323314332600_ref44","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.japh.2018.03.003","article-title":"Community pharmacist-directed point-of-care group A Streptococcus testing: evaluation of a Canadian program","volume":"58","author":"Papastergiou","year":"2018","journal-title":"J Am Pharm Assoc (2003)"},{"key":"2025120323314332600_ref45","doi-asserted-by":"publisher","first-page":"e4726","DOI":"10.7717\/peerj.4726","article-title":"A survey of the views and capabilities of community pharmacists in Western Australia regarding the rescheduling of selected oral antibiotics in a framework of pharmacist prescribing","volume":"6","author":"Sinkala","year":"2018","journal-title":"PeerJ"},{"key":"2025120323314332600_ref46","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11096-016-0396-0","article-title":"Assessing pharmacists\u2019 readiness to prescribe oral antibiotics for limited infections using a case-vignette technique","volume":"39","author":"Ung","year":"2017","journal-title":"Int J Clin Pharm"},{"key":"2025120323314332600_ref47","doi-asserted-by":"publisher","DOI":"10.1186\/s13012-016-0437-z","article-title":"A systematic review of the use of the Consolidated Framework for Implementation Research","volume":"11","author":"Kirk","year":"2016","journal-title":"Implement Sci"},{"key":"2025120323314332600_ref48","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13012-015-0209-1","article-title":"A refined compilation of implementation strategies: results from the Expert Recommendations for Implementing Change (ERIC) project","volume":"10","author":"Powell","year":"2015","journal-title":"Implement Sci"},{"key":"2025120323314332600_ref49","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13012-015-0295-0","article-title":"Use of concept mapping to characterize relationships among implementation strategies and assess their feasibility and importance: results from the Expert Recommendations for Implementing Change (ERIC) study","volume":"10","author":"Waltz","year":"2015","journal-title":"Implement Sci"},{"key":"2025120323314332600_ref50","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13012-019-0876-4","article-title":"Specifying and comparing implementation strategies across seven large implementation interventions: a practical application of theory","volume":"14","author":"Perry","year":"2019","journal-title":"Implement Sci"},{"key":"2025120323314332600_ref51","doi-asserted-by":"publisher","first-page":"102192","DOI":"10.1016\/j.japh.2024.102192","article-title":"The community pharmacist as an independent prescriber: a scoping review","volume":"64","author":"Piraux","year":"2024","journal-title":"J Am Pharm Assoc (2003)"},{"key":"2025120323314332600_ref52","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/1748-5908-8-109","article-title":"Factors influencing pharmacists\u2019 adoption of prescribing: qualitative application of the diffusion of innovations theory","volume":"8","author":"Makowsky","year":"2013","journal-title":"Implement Sci"},{"key":"2025120323314332600_ref53","volume-title":"Implementing the Global Action Plan on Antimicrobial Resistance: First Quadripartite Biennial Report","author":"World Health Organization","year":"2023"},{"key":"2025120323314332600_ref54","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1177\/1715163521999417","article-title":"Community pharmacist prescribing of antimicrobials: a systematic review from an antimicrobial stewardship perspective","volume":"154","author":"Wu","year":"2021","journal-title":"Can Pharm J (Ott)"},{"key":"2025120323314332600_ref55","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/antibiotics10010063","article-title":"Are we making the most of community pharmacies? Implementation of antimicrobial stewardship measures in community pharmacies: a narrative review","volume":"10","author":"Rusic","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"2025120323314332600_ref56","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/ijpp.12431","article-title":"An underutilised resource for Antimicrobial Stewardship: a \u2018snapshot\u2019 of the community pharmacists\u2019 role in delayed or \u2018wait and see\u2019 antibiotic prescribing","volume":"26","author":"Avent","year":"2018","journal-title":"Int J Pharm Pract"},{"key":"2025120323314332600_ref57","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/ijpp.12557","article-title":"Barriers to pharmacist prescribing: a scoping review comparing the UK, New Zealand, Canadian and Australian experiences","volume":"27","author":"Zhou","year":"2019","journal-title":"Int J Pharm Pract"},{"key":"2025120323314332600_ref58","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jphys.2017.09.001","article-title":"Barriers to and facilitators of independent non-medical prescribing in clinical practice: a mixed-methods systematic review","volume":"63","author":"Noblet","year":"2017","journal-title":"J Physiother"},{"key":"2025120323314332600_ref59","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/hex.12639","article-title":"Patient and public perspectives of community pharmacies in the United Kingdom: a systematic review","volume":"21","author":"Hindi","year":"2018","journal-title":"Health Expect"},{"key":"2025120323314332600_ref60","doi-asserted-by":"publisher","first-page":"e13827","DOI":"10.1111\/ijcp.13827","article-title":"Pharmacist non-medical prescribing in primary care. A systematic review of views, opinions, and attitudes","volume":"75","author":"Mills","year":"2021","journal-title":"Int J Clin Pract"},{"key":"2025120323314332600_ref61","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1007\/s11096-024-01733-x","article-title":"Investigating practice integration of independent prescribing by community pharmacists using normalization process theory: a cross-sectional survey","volume":"46","author":"Karim","year":"2024","journal-title":"Int J Clin Pharm"},{"key":"2025120323314332600_ref62","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1177\/1715163519865759","article-title":"Barriers to a full scope of pharmacy practice in primary care: a systematic review of pharmacists\u2019 access to laboratory testing","volume":"152","author":"Donovan","year":"2019","journal-title":"Can Pharm J (Ott)"},{"key":"2025120323314332600_ref63","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.sapharm.2022.09.010","article-title":"Health information communication technology evaluation frameworks for pharmacist prescribing: a systematic scoping review","volume":"19","author":"Ogundipe","year":"2023","journal-title":"Res Social Adm Pharm"},{"key":"2025120323314332600_ref64","doi-asserted-by":"publisher","first-page":"n2061","DOI":"10.1136\/bmj.n2061","article-title":"A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance","volume":"374","author":"Skivington","year":"2021","journal-title":"BMJ"}],"container-title":["International Journal of Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ijpp\/article-pdf\/33\/6\/597\/63959171\/riaf063.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ijpp\/article-pdf\/33\/6\/597\/63959171\/riaf063.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T04:31:51Z","timestamp":1764822711000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijpp\/article\/33\/6\/597\/8222532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":64,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,8,5]]},"published-print":{"date-parts":[[2025,11,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ijpp\/riaf063","relation":{},"ISSN":["0961-7671","2042-7174"],"issn-type":[{"value":"0961-7671","type":"print"},{"value":"2042-7174","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,8,5]]}}}